-
2-APB for Intracellular Calcium Signaling
2026-08-24
2-APB is a practical, cell-permeable tool for separating IP3-mediated calcium release from downstream calcium entry and cell-fate responses. This workflow-focused guide covers concentration selection, calcium imaging, SOCE inhibition, mechanistic controls, and troubleshooting for oxidative stress and ischemia-reperfusion studies.
-
Dehydroabietic Acid Meets Adipocyte CRISPRi
2026-08-23
Dehydroabietic acid offers a pharmacological complement to adipocyte-targeted Fabp4 CRISPRi. This article develops a causal assay framework for separating PPAR-driven lipid metabolism regulation from gene-specific adipocyte effects.
-
Topotecan HCl: Reliable Cytotoxicity Assays
2026-08-22
This scenario-driven guide shows how Topotecan HCl, SKU B2296, can improve interpretation and execution of cancer cell viability, proliferation, and cytotoxicity assays. It covers mechanism, solvent compatibility, exposure design, endpoint selection, and evidence-based product evaluation.
-
Phosphatase Inhibitor Cocktail 1 for Signaling
2026-08-22
Phosphatase Inhibitor Cocktail 1 supports reliable protein phosphorylation preservation across Western blotting, co-immunoprecipitation, kinase assays, and phosphoproteomic analysis. This workflow-focused guide shows how to protect labile signaling states while adapting sample preparation to the heterogeneous BET-response biology reported in HPV16-positive head and neck cancer.
-
AICAR phosphate (Acadesine): Assay Guide
2026-08-21
Learn how AICAR phosphate (Acadesine), SKU B1211, can support controlled viability, proliferation, and apoptosis workflows through AMPK-linked mechanisms. This scenario-based guide covers concentration design, solvent compatibility, interpretation of B-CLL responses, and practical reagent-selection criteria.
-
Calnexin Shapes CFTR Variant Rescue
2026-08-20
Tedman et al. used deep mutational scanning to show that the ER chaperone calnexin influences both CFTR surface expression and corrector responsiveness in a variant-dependent manner. The study provides a proteostasis-aware framework for interpreting CFTR modulator sensitivity beyond the F508del genotype alone.
-
SM-164 Workflows for IAP-Targeted Apoptosis Research
2026-08-20
SM-164 is a bivalent Smac mimetic for connecting IAP degradation, TNFα signaling, and caspase-dependent death in cancer research. This practical guide combines concentration-setting, orthogonal apoptosis readouts, and a Pol II-focused assay strategy to help distinguish pathway activation from nonspecific transcriptional stress.
-
DNA Damage and Selective CUX2 Neuron Loss
2026-08-19
The reference study identifies accumulated DNA damage and insufficient repair as a mechanistic explanation for the selective vulnerability of CUX2-positive layer 2/3 excitatory neurons during neuroinflammation. By integrating human multiple sclerosis tissue, mouse inflammatory models, neuronal genetic perturbation, and interferon-γ experiments, it connects inflammatory signaling, reactive oxygen species, double-strand break repair, and cell-type-specific neuronal loss.
-
Bufalin–CRISPR Nanomedicine for Colorectal Cancer
2026-08-19
The reference study introduces a calcium lactate nanomedicine that co-delivers bufalin and a CRISPR/Cas9 ribonucleoprotein targeting CD47. By combining tumor-cell apoptosis and pyroptosis with M2-to-M1 macrophage reprogramming and enhanced phagocytosis, the platform aims to connect local cytotoxicity with systemic antitumor immunity.
-
ALDH2 Synthetic Lethality in APC-Deficient CRC
2026-08-18
Liang and colleagues report that pharmacological ALDH2 inhibition with Disulfiram selectively compromises APC-deficient colorectal cancer models. The study links this vulnerability to progressive ROS accumulation and activation of the ASK1/JNK apoptotic pathway, providing a genotype-informed framework for colorectal cancer research.
-
HA-LNP PTEN mRNA for Transdermal Melanoma Therapy
2026-08-18
The reference study develops a hyaluronate-conjugated lipid nanoparticle that delivers PTEN mRNA through the skin and targets CD44-expressing melanoma-associated cells. Its preclinical findings link localized PTEN restoration with reduced melanoma viability, immunogenic cell death, tumor growth inhibition, and enhanced antitumor immune activation.
-
gamma-Glu-Cys (γ-Glu-Cys): Workflow Guide
2026-08-17
gamma-Glu-Cys (γ-Glu-Cys), SKU B7887, provides a defined glutathione-biosynthesis intermediate for glutathione synthetase enzyme assays, pathway studies, and selected plant workflows. This guide covers preparation, storage, QC, and troubleshooting; the material is for scientific research only and is not intended for diagnostic, clinical, or therapeutic use.
-
Doxorubicin Beyond 2D: A Translational Roadmap
2026-08-17
Doxorubicin and Adriamycin remain powerful translational benchmarks when DNA damage biology is tested in physiologically relevant 3D cancer models.
-
Ciprofloxacin hydrochloride: Assay Workflows
2026-08-16
Ciprofloxacin hydrochloride is a mechanistically defined fluoroquinolone antibiotic for bacterial DNA replication studies, susceptibility testing, and carefully controlled cell-based experiments. This guide translates its preparation, comparator value, and emerging antiparasitic relevance into practical workflows with troubleshooting checkpoints.
-
Puromycin aminonucleoside: Renal Model Workflows
2026-08-15
Puromycin aminonucleoside provides a practical bridge from controlled podocyte stress assays to proteinuria and glomerular pathology in animal studies. This workflow-focused guide covers stock handling, assay design, model selection, mechanistic extensions, and troubleshooting for reproducible renal injury research.